Related Experiment Video
Updated: Sep 25, 2025

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Definitive Closure of the Patent Ductus Arteriosus in Preterm Infants and Subsequent Short-Term Respiratory Outcomes
Craig R Wheeler1, Elizabeth R Vogel2, Michael A Cusano3
1Department of Respiratory Care, Boston Children's Hospital, Boston, Massachusetts. craig.wheeler@childrens.harvard.edu.
Insights
Persistent patent ductus arteriosus (PDA) in preterm infants poses risks. This review covers PDA pathophysiology, treatment options including minimally invasive closure, and respiratory support outcomes post-intervention.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
Background:
- Persistent patent ductus arteriosus (PDA) is a common complication in preterm infants.
- Hemodynamically significant PDA can lead to severe clinical consequences, impacting cardiac performance and requiring careful management.
- Management strategies for PDA, including medical and surgical options, remain a subject of ongoing debate.
Purpose of the Study:
- To review the pathophysiology of hemodynamically significant PDA in preterm infants.
- To summarize current and emerging treatment options for PDA, including minimally invasive approaches.
- To examine respiratory support and outcomes following PDA closure in this vulnerable population.
Main Methods:
- Comprehensive literature review of studies on PDA in preterm infants.
- Analysis of pathophysiologic mechanisms, clinical manifestations, and management strategies.
- Evaluation of data on respiratory support and outcomes after PDA intervention.
Main Results:
- PDA management is complex, influenced by shunt severity and perinatal factors.
- Minimally invasive device closure is increasingly feasible, even in extremely premature infants.
- Respiratory support and outcomes post-closure vary and warrant further investigation.
Conclusions:
- Effective management of hemodynamically significant PDA in preterm infants is crucial.
- Minimally invasive closure represents a significant advancement in PDA treatment.
- Understanding respiratory support needs and long-term outcomes post-closure is essential for optimizing infant care.
Abstract:
A persistent patent ductus arteriosus (PDA) can have significant clinical consequences in preterm infants, depending on the degree of left-to-right shunting, its impact on cardiac performance, and associated perinatal risk factors that can mitigate or exacerbate the shunt. Although the best management strategy remains contentious, PDAs that have contraindications to, or have failed medical management have historically undergone surgical ligation. Recently smaller occluder devices and delivery systems have allowed for minimally invasive closure in the catheterization laboratory even in extremely premature infants. The present review summarizes the pathophysiologic manifestations, treatment options and management of hemodynamically significant PDA in preterm infants. Additionally, we review the available literature surrounding the respiratory support and outcomes of preterm infants following definitive PDA closure.
Related Concept Videos
Pulmonary Cycle: Exhalation
Breathing

